In response to the escalating threat of antimicrobial resistance, the Fleming Fund has undertaken significant efforts across numerous low- and middle-income countries. As a leading partner, DAI has played a pivotal role in establishing One Health governance systems, optimizing data integration, utilization and surveillance systems, while enhancing laboratory capacities and connectedness, including National Reference Laboratories and genomic sequencing capabilities. This collaborative effort has substantially improved antimicrobial resistance detection, surveillance and response. DAI's implementation of country grants has breathed new life into the fight against AMR in Bangladesh, Indonesia, Nigeria, and Pakistan. To date, DAI has revamped 48 laboratories and contributed to the development of over 25 policies and guidelines...and those numbers keep increasing. In 2022, our
DAI Pakistan team won the global antimicrobial stewardship prize from the AMR Industry Alliance for bringing antimicrobial resistance (AMR) awareness to the forefront of clinical care. So much to be proud of.